Form4insider filings, from the source

Company · CIK 0001305253 · SIC 2836 — Biological Products, (No Diagnostic Substances)

Eiger BioPharmaceuticals, Inc. · EIGR

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $3.9M · 13sales $8.5M · 16net −$4.6M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesNov 2001Oct 2004Aug 2007Jul 2010May 2013Mar 2016Feb 2019

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Feb 4, 2019 PForm 4 →Feb 6, 7:23 pm ESTDavid A CoryPresident and CEO, Director227$14.13$3,20858,678+0.39% plan?
Dec 20, 2018 PForm 4 →Dec 20, 8:29 pm ESTThomas John DietzDirector5,000$9.98$49,90010,000+100% plan?
Dec 6, 2018 PForm 4 →Dec 10, 4:05 pm ESTThomas John DietzDirector5,000$11.26$56,3005,000— plan?
Nov 29, 2018 PForm 4 →Nov 30, 2:26 pm ESTEldon C. Mayer IIIDirector4,000$10.21$40,84025,000+19.0% plan?
Oct 18, 2018 SForm 4 →Oct 22, 4:33 pm EDTINTERWEST PARTNERS X LP +510% Owner237,265$12.06$2,862,3211,362,327−14.8% plan?
Apr 2, 2018 SForm 4 →Apr 4, 5:18 pm EDTJoanne QuanChief Medical Officer4,000$10.00$40,0000−100% plan?
Apr 2, 2018 MForm 4 →Apr 4, 5:18 pm EDTJoanne QuanChief Medical Officer4,000$2.06$8,2404,000— plan?
Sep 1, 2017 PForm 4 →Sep 5, 6:20 pm EDTJeffrey S GlennDirector15,000$9.53$142,95031,355+91.7% plan?
Nov 17, 2016 PForm 4 →Nov 21, 5:11 pm ESTJeffrey S GlennDirector15,460$12.74$196,884460— plan?
Aug 18, 2016 PForm 4 →Aug 22, 1:43 pm EDTVivo Ventures VI, LLC +210% Owner187,500$16.00$3,000,00012,996— plan?
Aug 18, 2016 PForm 4 →Aug 19, 7:15 pm EDTDavid A CoryPresident and CEO, Director1,562$15.70$24,52358,451+2.75% plan?
Aug 18, 2016 PForm 4 →Aug 19, 6:52 pm EDTJames P ShafferChief Business Officer3,125$15.70$49,0635,620+125% plan?
Jun 20, 2016 PForm 4 →Jun 22, 2:55 pm EDTJames H WelchChief Financial Officer2,500$19.80$49,4902,500— plan?
Jun 13, 2016 PForm 4 →Jun 14, 6:45 pm EDTJames P ShafferChief Business Officer1,250$22.17$27,7182,495+100% plan?
May 19, 2016 PForm 4 →May 23, 6:37 pm EDTJames P ShafferChief Business Officer1,245$19.80$24,6531,245— plan?
Apr 6, 2015 SForm 4 →Apr 7, 4:38 pm EDTKrisztina M ZseboChief Executive Officer, Director47,931$18.20$872,2833,125−93.9% plan?
Apr 6, 2015 MForm 4 →Apr 7, 4:38 pm EDTKrisztina M ZseboChief Executive Officer, Director47,931$2.07$99,29051,056— plan?
Apr 2, 2015 SForm 4 →Apr 3, 4:12 pm EDTRebecque J LabaVP, Corporate Operations11,012$17.30$190,4532,895−79.2% plan?
Apr 2, 2015 MForm 4 →Apr 3, 4:12 pm EDTRebecque J LabaVP, Corporate Operations11,012$1.75$19,29613,907— plan?
Apr 1, 2015 SForm 4 →Apr 3, 4:09 pm EDTRyan K TakeyaVP, Manufacturing4,444$19.13$85,0141,432−75.6% plan?
Apr 1, 2015 MForm 4 →Apr 3, 4:09 pm EDTRyan K TakeyaVP, Manufacturing4,444$1.12$4,9775,876— plan?
Mar 9, 2015 SForm 4 →Mar 9, 9:03 pm EDTKrisztina M ZseboChief Executive Officer, Director47,931$24.80$1,188,5053,125−93.9% plan?
Mar 9, 2015 MForm 4 →Mar 9, 9:03 pm EDTKrisztina M ZseboChief Executive Officer, Director47,931$2.07$99,29051,056— plan?
Mar 6, 2015 SForm 4 →Mar 9, 8:42 pm EDTRebecque J LabaVP, Corporate Operations14,000$23.06$322,8202,895−82.9% plan?
Mar 6, 2015 MForm 4 →Mar 9, 8:42 pm EDTRebecque J LabaVP, Corporate Operations14,000$3.09$43,20016,895— plan?
Mar 5, 2015 SForm 4 →Mar 9, 8:58 pm EDTPeter HonigDirector9,700$23.74$230,2880−100% plan?
Mar 5, 2015 MForm 4 →Mar 9, 8:58 pm EDTPeter HonigDirector9,700$10.41$101,0105,000— plan?
Mar 2, 2015 SForm 4 →Mar 3, 9:13 pm ESTRyan K TakeyaVP, Manufacturing7,777$18.48$143,7191,432−84.4% plan?
Mar 2, 2015 MForm 4 →Mar 3, 9:13 pm ESTRyan K TakeyaVP, Manufacturing7,777$1.12$8,7109,209— plan?
Feb 9, 2015 SForm 4 →Feb 10, 6:15 pm ESTKrisztina M ZseboChief Executive Officer, Director47,931$15.86$760,3033,125−93.9% plan?
Feb 9, 2015 MForm 4 →Feb 10, 6:15 pm ESTKrisztina M ZseboChief Executive Officer, Director47,931$2.07$99,29051,056— plan?
Feb 6, 2015 SForm 4 →Feb 10, 6:19 pm ESTRebecque J LabaVP, Corporate Operations14,000$16.08$225,1202,895−82.9% plan?
Feb 6, 2015 MForm 4 →Feb 10, 6:19 pm ESTRebecque J LabaVP, Corporate Operations14,000$3.09$43,20016,895— plan?
Feb 2, 2015 SForm 4 →Feb 3, 6:21 pm ESTRyan K TakeyaVP, Manufacturing7,777$16.35$127,1541,432−84.4% plan?
Feb 2, 2015 MForm 4 →Feb 3, 6:21 pm ESTRyan K TakeyaVP, Manufacturing7,777$1.12$8,7109,209— plan?
Jan 9, 2015 SForm 4 →Jan 12, 6:28 pm ESTJeffrey J RudyVP, Clinical Operations10,000$18.51$185,1001,024−90.7% plan?
Jan 9, 2015 MForm 4 →Jan 12, 6:28 pm ESTJeffrey J RudyVP, Clinical Operations10,000$1.12$11,20011,024— plan?
Jan 7, 2015 SForm 4 →Jan 8, 6:42 pm ESTRebecque J LabaVP, Corporate Operations20,000$17.30$346,0002,895−87.4% plan?
Jan 7, 2015 MForm 4 →Jan 8, 6:42 pm ESTRebecque J LabaVP, Corporate Operations20,000$1.12$22,40022,895— plan?
Jan 6, 2015 SForm 4 →Jan 8, 6:43 pm ESTKrisztina M ZseboChief Executive Officer, Director41,302$17.51$723,1983,125−93.0% plan?
Jan 6, 2015 MForm 4 →Jan 8, 6:43 pm ESTKrisztina M ZseboChief Executive Officer, Director41,302$1.12$46,25844,427— plan?
Jan 2, 2015 SForm 4 →Jan 5, 8:44 pm ESTRyan K TakeyaVP, Manufacturing7,777$19.88$154,6071,432−84.4% plan?
Jan 2, 2015 MForm 4 →Jan 5, 8:44 pm ESTRyan K TakeyaVP, Manufacturing7,777$1.12$8,7109,209— plan?
Nov 28, 2001 PForm 4 →Nov 28, 2018, 8:51 pm ESTEldon C. Mayer IIIDirector21,000$9.90$207,99821,000— plan? late

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jan 7, 2019 AForm 4 →Jan 9, 4:15 pm ESTChristine MurrayDirector25,000——25,000—
Jan 3, 2019 AForm 4 →Jan 4, 5:51 pm ESTSriram RyaliChief Financial Officer90,000——90,000—
Apr 2, 2018 MForm 4 →Apr 4, 5:18 pm EDTJoanne QuanChief Medical Officer4,000——22,256—
Mar 14, 2018 AForm 4 →Mar 16, 8:26 pm EDTJeffrey S GlennDirector10,000——10,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:25 pm EDTEvan LohDirector10,000——10,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:24 pm EDTEldon C. Mayer IIIDirector10,000——10,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:23 pm EDTThomas John DietzDirector10,000——10,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:20 pm EDTDavid ApelianCOO and Ex. Medical Officer, Director37,000——37,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:19 pm EDTDavid A CoryPresident and CEO, Director190,000——190,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:17 pm EDTJames P ShafferChief Business Officer60,000——60,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:16 pm EDTJoanne QuanChief Medical Officer60,000——60,000—
Mar 14, 2018 AForm 4 →Mar 16, 8:14 pm EDTJames H WelchChief Financial Officer60,000——60,000—
Jan 5, 2018 AForm 4 →Jan 9, 6:11 pm ESTEldon C. Mayer IIIDirector25,000——25,000—
Jan 5, 2018 AForm 4 →Jan 9, 5:52 pm ESTDavid ApelianCOO and Ex. Medical Officer, Director150,000——150,000—
Sep 28, 2017 AForm 4 →Oct 6, 6:51 pm EDTDavid ApelianDirector25,000——25,000— late
Sep 15, 2017 AForm 4 →Sep 18, 5:33 pm EDTEvan LohDirector25,000——25,000—
Apr 12, 2017 AForm 4 →Apr 14, 2:32 pm EDTNina S KjellsonDirector10,000——10,000—
Apr 12, 2017 AForm 4 →Apr 13, 7:23 pm EDTCharles BramlageDirector10,000——10,000—
Apr 12, 2017 AForm 4 →Apr 13, 7:12 pm EDTEdgar EnglemanDirector, 10% Owner10,000——10,000—
Apr 12, 2017 AForm 4 →Apr 13, 6:11 pm EDTJeffrey S GlennDirector10,000——10,000—
Apr 12, 2017 AForm 4 →Apr 13, 5:48 pm EDTThomas John DietzDirector10,000——10,000—
Mar 9, 2017 AForm 4 →Mar 14, 7:37 pm EDTJoanne QuanChief Medical Officer30,000——30,000— late
Mar 9, 2017 AForm 4 →Mar 14, 7:33 pm EDTEduardo Bruno MartinsSVP, Liver and Infectious Dise30,000——30,000— late
Mar 9, 2017 AForm 4 →Mar 14, 7:30 pm EDTDavid A CoryPresident and CEO, Director133,000——133,000— late
Mar 9, 2017 AForm 4 →Mar 14, 7:26 pm EDTJames P ShafferChief Business Officer40,000——40,000— late
Mar 9, 2017 AForm 4 →Mar 14, 7:19 pm EDTJames H WelchChief Financial Officer40,000——40,000— late
Mar 28, 2016 AForm 4/A →Sep 15, 6:46 pm EDTNina S KjellsonDirector, 10% Owner25,000——25,000—
Mar 28, 2016 AForm 4/A →Sep 15, 5:39 pm EDTEdgar EnglemanDirector, 10% Owner25,000——25,000—
Mar 28, 2016 AForm 4/A →Sep 15, 2:47 pm EDTJeffrey S GlennDirector55,000——30,000—
Mar 28, 2016 AForm 4/A →Sep 15, 2:41 pm EDTThomas John DietzDirector48,000——23,000—
Mar 28, 2016 AForm 4/A →Sep 15, 2:29 pm EDTCharles BramlageDirector25,000——25,000—
Mar 28, 2016 AForm 4 →Apr 4, 7:53 pm EDTEdgar EnglemanDirector, 10% Owner25,000——25,000— late amended
Mar 28, 2016 AForm 4 →Apr 1, 7:17 pm EDTJeffrey S GlennDirector55,000——30,000— late amended
Mar 28, 2016 AForm 4 →Apr 1, 7:10 pm EDTThomas John DietzDirector48,000——23,000— late amended
Mar 28, 2016 AForm 4 →Apr 1, 7:03 pm EDTCharles BramlageDirector25,000——25,000— late amended
Mar 28, 2016 AForm 4 →Apr 1, 6:57 pm EDTNina S KjellsonDirector, 10% Owner25,000——25,000— late amended
Mar 23, 2016 AForm 4/A →Sep 15, 3:04 pm EDTJames H WelchChief Financial Officer57,571——57,571—
Mar 23, 2016 AForm 4/A →Sep 15, 3:01 pm EDTJames P ShafferChief Business Officer60,699——60,699—
Mar 23, 2016 AForm 4/A →Sep 15, 2:58 pm EDTJoanne QuanChief Medical Officer53,452——53,452—
Mar 23, 2016 AForm 4/A →Sep 15, 2:54 pm EDTEduardo Bruno MartinsSVP, Liver and Infectious Dise65,216——65,216—
Mar 23, 2016 AForm 4/A →Sep 15, 2:36 pm EDTDavid A CoryPresident and CEO, Director285,991——285,991—
Mar 23, 2016 AForm 4 →Mar 28, 9:50 pm EDTDavid A CoryPresident and CEO, Director285,991——285,991— amended
Mar 23, 2016 AForm 4 →Mar 28, 9:26 pm EDTEduardo Bruno MartinsSVP, Liver and Infectious Dise65,216——65,216— amended
Mar 23, 2016 AForm 4 →Mar 28, 9:23 pm EDTJoanne QuanChief Medical Officer53,452——53,452— amended
Mar 23, 2016 AForm 4 →Mar 28, 9:18 pm EDTJames P ShafferChief Business Officer60,699——60,699— amended
Mar 23, 2016 AForm 4 →Mar 28, 9:13 pm EDTJames H WelchChief Financial Officer57,571——57,571— amended
Jun 4, 2015 AForm 4 →Jun 5, 6:26 pm EDTMichael NarachiDirector10,000——50,000—
Jun 4, 2015 AForm 4 →Jun 5, 6:25 pm EDTPeter HonigDirector10,000——22,800—
Jun 4, 2015 AForm 4 →Jun 5, 6:24 pm EDTGraham K CooperDirector10,000——40,000—
Jun 4, 2015 AForm 4 →Jun 5, 6:24 pm EDTGregg H AltonDirector10,000——40,000—
Apr 6, 2015 MForm 4 →Apr 7, 4:38 pm EDTKrisztina M ZseboChief Executive Officer, Director47,931——645,717—
Apr 2, 2015 MForm 4 →Apr 3, 4:12 pm EDTRebecque J LabaVP, Corporate Operations11,012——150,726—
Apr 1, 2015 MForm 4 →Apr 3, 4:09 pm EDTRyan K TakeyaVP, Manufacturing4,444——139,574—
Mar 9, 2015 MForm 4 →Mar 9, 9:03 pm EDTKrisztina M ZseboChief Executive Officer, Director47,931——693,648—
Mar 6, 2015 MForm 4 →Mar 9, 8:42 pm EDTRebecque J LabaVP, Corporate Operations14,000——161,738—
Mar 5, 2015 MForm 4 →Mar 9, 8:58 pm EDTPeter HonigDirector9,700——12,800—
Mar 2, 2015 MForm 4 →Mar 3, 9:13 pm ESTRyan K TakeyaVP, Manufacturing7,777——144,018—
Feb 9, 2015 MForm 4 →Feb 10, 6:15 pm ESTKrisztina M ZseboChief Executive Officer, Director47,931——741,579—
Feb 6, 2015 MForm 4 →Feb 10, 6:19 pm ESTRebecque J LabaVP, Corporate Operations14,000——175,738—
Feb 2, 2015 MForm 4 →Feb 3, 6:21 pm ESTRyan K TakeyaVP, Manufacturing7,777——151,795—
Jan 9, 2015 MForm 4 →Jan 12, 6:28 pm ESTJeffrey J RudyVP, Clinical Operations10,000——181,738—
Jan 7, 2015 MForm 4 →Jan 8, 6:42 pm ESTRebecque J LabaVP, Corporate Operations20,000——189,738—
Jan 6, 2015 MForm 4 →Jan 8, 6:43 pm ESTKrisztina M ZseboChief Executive Officer, Director41,302——789,510—
Jan 1, 2015 AForm 4 →Jan 5, 8:56 pm ESTKrisztina M ZseboChief Executive Officer, Director275,000——830,812—
Jan 1, 2015 AForm 4 →Jan 5, 8:54 pm ESTRebecque J LabaVP, Finance and Administration80,000——209,738—
Jan 1, 2015 AForm 4 →Jan 5, 8:51 pm ESTPaul B ClevelandPresident and CFO140,000——417,500—
Jan 1, 2015 AMForm 4 →Jan 5, 8:44 pm ESTRyan K TakeyaVP, Manufacturing79,777——159,572—
Jan 1, 2015 AForm 4 →Jan 5, 8:44 pm ESTElizabeth E ReedVP, General Counsel72,000——142,500—
Jan 1, 2015 AForm 4 →Jan 5, 8:40 pm ESTJeffrey J RudyVP, Clinical Operations80,000——191,738—
Jan 1, 2015 AForm 4 →Jan 5, 8:36 pm ESTFredrik WiklundSee Remarks80,000——193,243—